Visit: 60 Corporate Woods, Suite 380 | Email: URVenturesInfo@urmc.rochester.edu | Phone: 585-276-6600
Everyone is talking about Dr. Nedergaard’s discovery. We can’t blame them. This has huge potential. But don’t take our word for it . . . . io9: http://bit.ly/1gOM5U3 Science Magazine: http://bit.ly/1hU0D8N NIH News Update: http://1.usa.gov/1kuEP5b Neuroscience News: http://bit.ly/MKUAWP NBC: http://nbcnews.to/1bXANQb BBC: http://bbc.in/1dXojTM NPR: http://n.pr/1ddsU37 NY
Stephen Dewhurst – 11 January 2014 “However beautiful the strategy, you should occasionally look at the results.” – Winston Churchill Every organization needs a clearly articulated mission, a vision of where it wants to go, and a plan of how it will achieve that vision.
Sunday Review Goodnight. Sleep Clean. By Maria Konnikova Jan. 11, 2014 SLEEP seems like a perfectly fine waste of time. Why would our bodies evolve to spend close to one-third of our lives completely out of it, when we could instead be doing something useful
NEW ORLEANS & ROCHESTER, N.Y.–(BUSINESS WIRE)–MiniVax, Inc. (New Orleans, LA) and the University of Rochester (Rochester, NY) announce that they have entered into an exclusive option agreement with agreed licensing terms to develop a monoclonal antibody for the treatment of Pneumocystis pneumonia (PCP). The antibody
Companies interested in entering should have a scalable business concept with high growth potential. Companies must be early-stage, as defined at the time of application by having less than $250,000 of outside cash investment and less than $500,000 in cumulative revenue (excluding research grants). The
Bennett J. Loudon, Staff Writer, Democrat & Chronicle The business community has a new resource to get help from experienced experts. The series, hosted by Alex Zapesochny, is an outgrowth of the efforts of the Entrepreneurship and Innovation Working Group of the Finger Lakes Regional
By Jennifer Roach 20 November 2013 The University’s Office of Technology Transfer has rebranded itself as UR Ventures with a new look, a new structure, and a renewed focus on technology development and commercialization. UR Ventures will provide the University’s technology transfer functions with an
ROCForward: November 2013 The University of Rochester Innovation Advisory Network gathered during Meliora Weekend in October for a conversation with Senior Vice President of Research Rob Clark and Associate Vice President for Innovation and Technology Commercialization Scott Catlin. Caitlin updated the group on the reorganization
by Stephen Dewhurst Over the weekend, I read a series of newspaper articles about the high price of college and the emergence of new, profit-seeking universities that offer degree programs at low cost. As a professor at a major research university, and the father of
Diagnostic Devices the Size of a Credit Card Are Now a Possibility The ability to shrink laboratory-scale processes to automated chip-sized systems would revolutionize biotechnology and medicine. For example, inexpensive and highly portable devices that process blood samples to detect biological agents such as anthrax
By WILL ASTOR Rochester Business Journal October 18, 2013 After spending some 15 years developing a local program to move mentally ill inmates out of the criminal justice system and keep them out, two University of Rochester Medical Center psychiatrists are winning national attention. read
After several months of intense self-reflection, the University of Rochester Office of Technology Transfer relaunched itself as UR Ventures today, 21 October 2013. UR Ventures has a new look, a new structure, and a renewed focus on technology commercialization. UR Ventures will provide the University’s technology